Next Article in Journal
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6
Next Article in Special Issue
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin
Previous Article in Journal
Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era
Previous Article in Special Issue
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
 
 
Article

Article Versions Notes

Cancers 2021, 13(5), 1053; https://doi.org/10.3390/cancers13051053
Action Date Notes Link
article xml file uploaded 2 March 2021 13:32 CET Original file -
article xml uploaded. 2 March 2021 13:32 CET Update -
article pdf uploaded. 2 March 2021 13:32 CET Version of Record https://www.mdpi.com/2072-6694/13/5/1053/pdf-vor
article supplementary file uploaded. 2 March 2021 13:32 CET - https://www.mdpi.com/2072-6694/13/5/1053#supplementary
article html file updated 2 March 2021 13:33 CET Original file -
article xml file uploaded 10 March 2021 08:30 CET Update -
article xml uploaded. 10 March 2021 08:30 CET Update https://www.mdpi.com/2072-6694/13/5/1053/xml
article pdf uploaded. 10 March 2021 08:30 CET Updated version of record https://www.mdpi.com/2072-6694/13/5/1053/pdf
article html file updated 10 March 2021 08:31 CET Update -
article html file updated 25 July 2022 05:46 CEST Update https://www.mdpi.com/2072-6694/13/5/1053/html
Back to TopTop